Cardiol Therapeutics CRDL
NASDAQ CRDL
$1.12 -0.03 (-2.61%)
At close: Oct 23, 2026 · 4:00 PM EDT

Cardiol Therapeutics (CRDL) Cash & Current Investments (2020 - 2026)

Updated

Cardiol Therapeutics (CRDL) posted Cash & Current Investments of $18.85 million for Q2 2026, up 43.6% from $13.13 million a year earlier but down 6.6% from the prior quarter.

Analysis

Cardiol Therapeutics (CRDL) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Cardiol Therapeutics' Cash & Current Investments came in at $15.33 million, down 31.4% from FY2024.

  • Annual Cash & Current Investments has declined for four consecutive years, though with a five-year compound annual growth rate of 7.9% (FY2020 to FY2025).
  • In prior years, Cardiol Therapeutics' Cash & Current Investments was $22.34 million in FY2024 (-13.0%), $25.66 million in FY2023 (-41.4%), $43.81 million in FY2022 (-34.6%) and $66.95 million in FY2021 (+539.5%).
  • Quarterly Cash & Current Investments has run from a low of $8.45 million in Q3 2025 to a high of $66.56 million in Q4 2021 over five years.
  • On a year-over-year basis, Cash & Current Investments increased in two of the last eight quarters, with an average decline of 14.3%.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q4 2021, with growth of 518.7%; the weakest was Q3 2024, with a decline of 61.5%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $20.18 million (Q1 2026), $15.36 million (Q4 2025) and $8.45 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Cardiol Therapeutics 96.99 Mn 34.78 Mn - 18.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.36 Mn
Mar 31, 2026 19.87 Mn
Dec 31, 2025 15.64 Mn
Sep 30, 2025 8.35 Mn
Jun 30, 2025 13.30 Mn
Mar 31, 2025 16.28 Mn
Dec 31, 2024 21.31 Mn
Sep 30, 2024 11.76 Mn
Jun 30, 2024 17.53 Mn
Mar 31, 2024 21.11 Mn
Dec 31, 2023 26.40 Mn
Sep 30, 2023 30.05 Mn
Jun 30, 2023 33.92 Mn
Mar 31, 2023 36.58 Mn
Dec 31, 2022 43.88 Mn
Sep 30, 2022 47.92 Mn
Jun 30, 2022 54.69 Mn
Mar 31, 2022 59.96 Mn
Dec 31, 2021 65.83 Mn
Sep 30, 2021 22.47 Mn
API Access

Cardiol Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CRDL&period=max&api_key=YOUR_API_KEY